Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

Hyundai Motor India Charts Ambitious Comeback: ₹45,000 Crore Investment, 26 New Models to Regain No. 2 Spot

Auto

|

Updated on 06 Nov 2025, 08:39 am

Whalesbook Logo

Reviewed By

Satyam Jha | Whalesbook News Team

Short Description :

Hyundai Motor India is planning a strong resurgence to reclaim its second position in the Indian passenger vehicle market. The company announced a significant investment of ₹45,000 crore by fiscal year 2030, which will fund the launch of 26 new models, including electric and hybrid vehicles. Tarun Garg, set to become MD and CEO in 2026, emphasized a focus on responsible growth, manufacturing capacity expansion, and increased localization. The launch of the all-new Hyundai Venue, now manufactured in India for global markets, is part of this strategy.
Hyundai Motor India Charts Ambitious Comeback: ₹45,000 Crore Investment, 26 New Models to Regain No. 2 Spot

▶

Stocks Mentioned :

Mahindra & Mahindra Limited
Tata Motors Limited

Detailed Coverage :

Hyundai Motor India is preparing for a significant push to regain its coveted second position in the competitive Indian passenger vehicle market. The company has laid out an ambitious vision, backed by a substantial investment of ₹45,000 crore planned by fiscal year 2030. This investment will fuel the introduction of 26 new products, encompassing a range of electric and hybrid vehicles, to cater to evolving market demands.

Tarun Garg, the current Whole-Time Director and COO who will take over as Managing Director and CEO from January 1, 2026, stated that the company's growth will be competitive and responsible, prioritizing fundamentals over sheer volume. He highlighted the importance of maintaining equilibrium between domestic and export markets, and balancing growth with responsibility.

Hyundai aims to leverage new models, enhanced production capacity, and a broader offering of electric and hybrid vehicles to reclaim the No. 2 market share position, which has recently seen challenges from rivals like Mahindra and Tata Motors. The automaker has already launched the all-new Hyundai Venue and Venue N Line, with the compact SUV now being manufactured exclusively in India for global markets, reinforcing its 'Make in India for the World' initiative. The compact SUV segment, particularly, has seen robust demand following GST reforms that benefit vehicles under 4 meters. Garg noted that SUVs continue to dominate sales, with customers increasingly upgrading to larger vehicles.

Impact This news is highly impactful for Hyundai Motor India's strategic direction and future market performance. The significant investment signals strong commitment to the Indian market, potentially boosting its stock value if the parent company's stock is considered or impacting investor sentiment towards the Indian auto sector overall. The focus on localization and new products could enhance its competitiveness against domestic players, leading to increased market share and revenue. The "Make in India for the World" aspect also bolsters India's manufacturing reputation. Impact Rating: 7/10

Difficult Terms Explained: Localization: The process of designing, manufacturing, and sourcing components or products within the country where they will be sold, reducing reliance on imports. GST: Goods and Services Tax, a unified indirect tax system in India. SUV: Sport Utility Vehicle, a type of vehicle combining elements of road-going passenger cars with features from off-road vehicles such as raised ground clearance and four-wheel drive. Hatchback: A car body configuration with a rear door (hatch) that swings upward to provide access to the cargo area.

More from Auto

Ola Electric Reports Significant Revenue Drop but Auto Segment Turns Profitable

Auto

Ola Electric Reports Significant Revenue Drop but Auto Segment Turns Profitable

Mahindra & Mahindra Reports Strong Q2FY26 with Margin Growth and Robust EV and Farm Segment Performance

Auto

Mahindra & Mahindra Reports Strong Q2FY26 with Margin Growth and Robust EV and Farm Segment Performance

Ola Electric Reports 15% Net Loss Reduction in Q2 FY26, Automotive Segment Turns Profitable

Auto

Ola Electric Reports 15% Net Loss Reduction in Q2 FY26, Automotive Segment Turns Profitable

Mahindra & Mahindra Sells RBL Bank Stake for ₹678 Crore, Realizing 62.5% Profit

Auto

Mahindra & Mahindra Sells RBL Bank Stake for ₹678 Crore, Realizing 62.5% Profit

Ola Electric Stock Declines Ahead of Q3 Results; Analysts Expect Narrower Losses

Auto

Ola Electric Stock Declines Ahead of Q3 Results; Analysts Expect Narrower Losses

Mahindra & Mahindra Stock Rallies on Strong Q2 Earnings and RBL Bank Stake Sale

Auto

Mahindra & Mahindra Stock Rallies on Strong Q2 Earnings and RBL Bank Stake Sale


Latest News

Vedanta Secures 500 MW Power Supply Pact with Tamil Nadu for Five Years

Energy

Vedanta Secures 500 MW Power Supply Pact with Tamil Nadu for Five Years

Indian Equity Markets Close Lower Amid Volatility and Profit Booking

Economy

Indian Equity Markets Close Lower Amid Volatility and Profit Booking

Cholamandalam Investment Reports 20% Profit Growth in Q2FY26 Amid Rising NPAs

Banking/Finance

Cholamandalam Investment Reports 20% Profit Growth in Q2FY26 Amid Rising NPAs

India Services Sector Growth Slows to 5-Month Low in October

Economy

India Services Sector Growth Slows to 5-Month Low in October

India's Consumer Sector Faces Sweeping Leadership Overhaul

Consumer Products

India's Consumer Sector Faces Sweeping Leadership Overhaul

India’s Richest Donate Record Rs 10,380 Crore in 2025, Education Top Priority

Economy

India’s Richest Donate Record Rs 10,380 Crore in 2025, Education Top Priority


Healthcare/Biotech Sector

Sun Pharma's US Innovative Drug Sales Surpass Generics for First Time

Healthcare/Biotech

Sun Pharma's US Innovative Drug Sales Surpass Generics for First Time

Zydus Lifesciences Reports 39% Profit Growth in Q2 FY26, Plans ₹5,000 Crore Fundraising

Healthcare/Biotech

Zydus Lifesciences Reports 39% Profit Growth in Q2 FY26, Plans ₹5,000 Crore Fundraising

Abbott India Reports 16% Profit Jump on Strong Revenue and Margins

Healthcare/Biotech

Abbott India Reports 16% Profit Jump on Strong Revenue and Margins

Indoco Remedies Posts Improved Q2 Earnings, Stock Sees Gains

Healthcare/Biotech

Indoco Remedies Posts Improved Q2 Earnings, Stock Sees Gains

Medi Assist Healthcare Profit Drops 61.6% Amidst Acquisition and Tech Investments

Healthcare/Biotech

Medi Assist Healthcare Profit Drops 61.6% Amidst Acquisition and Tech Investments

Zydus Lifesciences' Beta-Thalassemia Drug Desidustat Receives USFDA Orphan Drug Designation

Healthcare/Biotech

Zydus Lifesciences' Beta-Thalassemia Drug Desidustat Receives USFDA Orphan Drug Designation


Mutual Funds Sector

Domestic Funds Rapidly Closing Gap with Foreign Investors in Indian Markets

Mutual Funds

Domestic Funds Rapidly Closing Gap with Foreign Investors in Indian Markets

State Bank of India to Divest 6.3% Stake in SBI Funds Management via IPO

Mutual Funds

State Bank of India to Divest 6.3% Stake in SBI Funds Management via IPO

Indian Investors Turn to Direct Mutual Fund Plans in 2025 for Cost Savings and Enhanced Portfolio Control

Mutual Funds

Indian Investors Turn to Direct Mutual Fund Plans in 2025 for Cost Savings and Enhanced Portfolio Control

Helios Mutual Fund Launches New India Small Cap Fund

Mutual Funds

Helios Mutual Fund Launches New India Small Cap Fund

Kotak Mahindra AMC Launches New Fund Focused on India's Rural Growth Opportunities

Mutual Funds

Kotak Mahindra AMC Launches New Fund Focused on India's Rural Growth Opportunities

Equitree Capital Advisors Surpasses ₹1,000 Crore in Assets Under Management

Mutual Funds

Equitree Capital Advisors Surpasses ₹1,000 Crore in Assets Under Management

More from Auto

Ola Electric Reports Significant Revenue Drop but Auto Segment Turns Profitable

Ola Electric Reports Significant Revenue Drop but Auto Segment Turns Profitable

Mahindra & Mahindra Reports Strong Q2FY26 with Margin Growth and Robust EV and Farm Segment Performance

Mahindra & Mahindra Reports Strong Q2FY26 with Margin Growth and Robust EV and Farm Segment Performance

Ola Electric Reports 15% Net Loss Reduction in Q2 FY26, Automotive Segment Turns Profitable

Ola Electric Reports 15% Net Loss Reduction in Q2 FY26, Automotive Segment Turns Profitable

Mahindra & Mahindra Sells RBL Bank Stake for ₹678 Crore, Realizing 62.5% Profit

Mahindra & Mahindra Sells RBL Bank Stake for ₹678 Crore, Realizing 62.5% Profit

Ola Electric Stock Declines Ahead of Q3 Results; Analysts Expect Narrower Losses

Ola Electric Stock Declines Ahead of Q3 Results; Analysts Expect Narrower Losses

Mahindra & Mahindra Stock Rallies on Strong Q2 Earnings and RBL Bank Stake Sale

Mahindra & Mahindra Stock Rallies on Strong Q2 Earnings and RBL Bank Stake Sale


Latest News

Vedanta Secures 500 MW Power Supply Pact with Tamil Nadu for Five Years

Vedanta Secures 500 MW Power Supply Pact with Tamil Nadu for Five Years

Indian Equity Markets Close Lower Amid Volatility and Profit Booking

Indian Equity Markets Close Lower Amid Volatility and Profit Booking

Cholamandalam Investment Reports 20% Profit Growth in Q2FY26 Amid Rising NPAs

Cholamandalam Investment Reports 20% Profit Growth in Q2FY26 Amid Rising NPAs

India Services Sector Growth Slows to 5-Month Low in October

India Services Sector Growth Slows to 5-Month Low in October

India's Consumer Sector Faces Sweeping Leadership Overhaul

India's Consumer Sector Faces Sweeping Leadership Overhaul

India’s Richest Donate Record Rs 10,380 Crore in 2025, Education Top Priority

India’s Richest Donate Record Rs 10,380 Crore in 2025, Education Top Priority


Healthcare/Biotech Sector

Sun Pharma's US Innovative Drug Sales Surpass Generics for First Time

Sun Pharma's US Innovative Drug Sales Surpass Generics for First Time

Zydus Lifesciences Reports 39% Profit Growth in Q2 FY26, Plans ₹5,000 Crore Fundraising

Zydus Lifesciences Reports 39% Profit Growth in Q2 FY26, Plans ₹5,000 Crore Fundraising

Abbott India Reports 16% Profit Jump on Strong Revenue and Margins

Abbott India Reports 16% Profit Jump on Strong Revenue and Margins

Indoco Remedies Posts Improved Q2 Earnings, Stock Sees Gains

Indoco Remedies Posts Improved Q2 Earnings, Stock Sees Gains

Medi Assist Healthcare Profit Drops 61.6% Amidst Acquisition and Tech Investments

Medi Assist Healthcare Profit Drops 61.6% Amidst Acquisition and Tech Investments

Zydus Lifesciences' Beta-Thalassemia Drug Desidustat Receives USFDA Orphan Drug Designation

Zydus Lifesciences' Beta-Thalassemia Drug Desidustat Receives USFDA Orphan Drug Designation


Mutual Funds Sector

Domestic Funds Rapidly Closing Gap with Foreign Investors in Indian Markets

Domestic Funds Rapidly Closing Gap with Foreign Investors in Indian Markets

State Bank of India to Divest 6.3% Stake in SBI Funds Management via IPO

State Bank of India to Divest 6.3% Stake in SBI Funds Management via IPO

Indian Investors Turn to Direct Mutual Fund Plans in 2025 for Cost Savings and Enhanced Portfolio Control

Indian Investors Turn to Direct Mutual Fund Plans in 2025 for Cost Savings and Enhanced Portfolio Control

Helios Mutual Fund Launches New India Small Cap Fund

Helios Mutual Fund Launches New India Small Cap Fund

Kotak Mahindra AMC Launches New Fund Focused on India's Rural Growth Opportunities

Kotak Mahindra AMC Launches New Fund Focused on India's Rural Growth Opportunities

Equitree Capital Advisors Surpasses ₹1,000 Crore in Assets Under Management

Equitree Capital Advisors Surpasses ₹1,000 Crore in Assets Under Management